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Process development for large-scale ex vivo expansion
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LabCell
INTRODUCTION
2. Stirred-Tank Reactor (STR)
PROS CONS
• High scalability, standardization, and reproducibility
• Easy to monitor and control temperature, pH, dO2, dCO2
• Saving on operating (labor) cost and preparing time
• Closed system- safe, simple and clean
• Shear stress to sensitive cells, causing low yield
1. Engineering Parameters for Scale-Up
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- Geometry of Bioreactors - Shear Stress
- Mass Transfer
2. Computational Fluid 
Dynamics (CFD)
• ANSYS Software Student Ver. 19.2 
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Natural killer (NK) cells are a type of lymphocytes in the blood that are responsible for innate and adaptive immune response and they
mature in the liver and bone marrow. Being a key role in host defense system with direct and indirect killing of virus-infected cells or
cancer cells, NK cell has been considered an attractive candidate for cancer therapy. Peripheral blood shows the low frequency of NK
cells, so the ex vivo expansion method is important to obtain sufficient NK cells for therapeutic use.
4. Aim : Manufacturing Scale-Up with Comparability to Lab Scale Bioreactor
1. Natural Killer (NK) Cell
3. Schematic Representation of ex vivo Expansion of NK Cells at Manufacturing Scale
NK Cell Enrichment ex vivo NK Cell ExpansionHealthy Donor Patient




Stirred-tank bioreactor could be considered as an optimal alternative system for large-scale NK cell expansion compared with other
ones because it is automated, less labor-intensive, scalable, well-controlled and cost-effective. We firstly developed a lab-scale
bioreactor process for ex vivo expansion of NK cell in the world. With the need for reduction in production cost and easy-to-control








It is necessary to provide homogenous culture conditions. So we studied effects of agitation at manufacturing-scale (50 L) and figured 
out an optimum condition based on the comparability to the lab-scale (2 L) bioreactor, for which In-Process Control (IPC) and Quality 
Control (QC) were carried out in terms of growth rate, viability cytotoxicity, and purity.
METHOD
Comparability between Different Scale Bioreactors in ex vivo NK Cell Expansion
• Viable Cell Density (VCD)
• Viability











ADVANCED PARAMETERS CORRELATION (2 L AND 50 L STR)
Figure 1. Comparison of velocity distribution on coordinate frame (x-, y-, z-axis) at lab-scale (2 L) and manufacturing-scale (50 L).
Contour graphs on xz-plane (left) and scatter graphs (right) on z-axis represented a) u velocity (x-direction) at 2 L scale and 50 L scale
(ave. 0.011 m s-1 and ave. 0.020 m s-1, respectively), b) v velocity (y-direction) at 2 L scale and 50 L scale (ave. 0.011 m s-1 and ave. 0.020
m s-1, respectively), and c) w velocity (z-direction) at 2 L scale and 50 L scale (ave. 0.029 m s-1 and ave. 0.034 m s-1, respectively)
2 L
50 L
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CONCLUSION
Bioreactor process at 50 L scale was demonstrated to be comparable as at 2 L scale in producing allogeneic NK cells. Scale-up parameters were
optimized with classical engineering parameters and advanced engineering parameters. The similarity of classical parameters (power input
(P/V), Newton number (Ne), geometry) helped to calculate which RPM could be operated at 50 L scale. In addition to that, Infinitesimal
analysis based on advanced parameters, showed that 50 L scale operation with the RPM lowered shear stress but increased turbulent kinetic
energy. Under the circumstance, PDL (~12), viability (>95%), cytotoxicity, and purity (>99% of CD3-CD56+) of cells at 50 L scale were almost








2 L 50 L
Population doubling level (PDL), viability, the cumulative concentration of glucose consumed and lactate produced were measured with time. All
the IPC data at 50-L scale showed to be comparable with 2 L scale. Harvested NK cells from 50 L bioreactor were analyzed for cytotoxicity and purity.
It was confirmed that manufacturing scale cultivation was also comparable with its cytotoxicity against K562 cells and purity.
PERFORMANCE COMPARISON OF SCALES
Lab scale bioreactor (N=8)
Production scale bioreactor (N=1)
Figure 2. Shear strain rate (SSR) at 2 L scale and 50 L scale (5.98 s-
1 and 3.74 s-1 respectively)
Figure 3. Turbulent kinetic energy (TKE) at 2 L scale and 50 L scale
(0.82 J kg-1 and 1.20 J kg-1, respectively)
Figure 4. Comparability test for a)
population doubling level (PDL), b) viability,
concentration of c) glucose consumed and
d) lactate produced, e) cytotoxicity against
K562, and f) purity between lab-scale
bioreactor (2 L) (N=8) and manufacturing-
scale bioreactor (50 L), indicated by red and
blue color, respectively
Computational Fluid Dynamics (CFD) simulation has become a widely applicable numerical technique for understanding local properties
(e.g., fluid velocity, gas holdup, and shear stress). Navier-Stokes equation is basic for calculating flow dynamics with time, and its derived
modeling relating to turbulence is introduced to predict advanced parameters. Shear strain rate (SSR) and turbulent kinetic energy (TKE)
are the most two well-known parameters to study cell damage in cultivation and mass transfer, respectively.
Applying calculated RPM to operation at 50 L scale, x, y, z-axis velocities (u, v, w) were 1.83, 1.84, 1.18-fold faster than in 2 L scale, respectively
(Fig. 1). Distribution of faster velocity generally causes the shear field to become intense, which can raise the issues in cell damage during
cultivation. CFD results, however, showed the reduction in shear strain rate by 37.4% in scaling up to 50 L (Fig. 2), and turbulent kinetic energy
(TKE) of 50 L bioreactor got more increased by 47.3% along Z-axis than of 2 L bioreactor (Fig. 3). Both macroscopic similarity and infinitesimal
analysis via CFD demonstrated that scale-up to 50 L could lower SSR and enhance TKE with the comparability to 2 L scale bioreactor process,























































































































CLASSICAL PARAMETERS CORRELATION (2 L AND 50 L STR)
Basic parameters including two dimensionless numbers, power input (P/V) and Newton number (Ne) are applied to scale up bioreactor
process. P/V2L and Ne2L were calculated based on the optimal condition where NK cells were well cultivated at lab-scale bioreactor (2 L).
The same values of them at manufacturing scale (50 L) (P/V50L and Ne50L) can determine agitation speed (RPM) in 50 L bioreactor process.
This scale-up process could be expected to show comparable performance compared with 2 L scale.
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